Context Therapeutics reported earnings of -$ 0.08 per CNTX share on Nov 10, 2026, falling short of analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.11 |
| Earnings Per Share (Surprise) | -$ 0.08 (+$ 0.02756) |
| Last Year's EPS | -$ 0.10 |
| EPS YoY Change |
Out of the last 28 earnings reporting periods, Context Therapeutics beat analysts’ expectations 8 times and fell short of expectations 11 time(s). Context Therapeutics reported earnings per share of -$ 0.08 in the last report surpassing an estimated EPS of -$ 0.11 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.11 | -$ 0.08 | -$ 0.10 | |
| Aug 5, 2026 | -$ 0.09 | -$ 0.15 | -$ 0.09 | |
| May 6, 2026 | -$ 0.12 | -$ 0.09 | -$ 0.05 | |
| Mar 19, 2026 | -$ 0.11 | -$ 0.14 | -$ 0.04 | |
| Nov 5, 2025 | -$ 0.09 | -$ 0.10 | -$ 0.22 | |
| Aug 6, 2025 | -$ 0.06 | -$ 0.09 | -$ 0.04 | |
| May 7, 2025 | -$ 0.05 | -$ 0.05 | -$ 0.23 | |
| Mar 20, 2025 | -$ 0.05 | -$ 0.04 | -$ 0.42 | |
| Nov 6, 2024 | -$ 0.11 | -$ 0.22 | -$ 0.37 | |
| Aug 7, 2024 | -$ 0.08 | -$ 0.04 | -$ 0.31 | |
| May 8, 2024 | -$ 0.38 | -$ 0.23 | -$ 0.40 | |
| Mar 21, 2024 | -$ 0.35 | -$ 0.42 | -$ 0.22 | |
| Nov 9, 2023 | -$ 0.30 | -$ 0.37 | -$ 0.24 | |
| Aug 9, 2023 | -$ 0.20 | -$ 0.31 | -$ 0.25 | |
| May 10, 2023 | -$ 0.19 | -$ 0.40 | -$ 0.22 | |
| Mar 22, 2023 | -$ 0.30 | -$ 0.22 | -$ 0.30 | |
| Nov 9, 2022 | -$ 0.25 | -$ 0.24 | -$ 0.58 | |
| Aug 11, 2022 | -$ 0.25 | -$ 0.25 | -$ 4.00 | |
| May 11, 2022 | -$ 0.24 | -$ 0.22 | -$ 0.73 | |
| Mar 24, 2022 | -$ 0.27 | -$ 0.30 | -$ 0.09 |
Context Therapeutics’s stock was trading at $ 0.2003 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, CNTX’s price increased to $ 0.2161 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.08 | $ 0.2003 | $ 0.2161 | |
| Aug 5, 2026 | -$ 0.15 | $ 0.6218 | $ 0.504 | |
| May 6, 2026 | -$ 0.09 | $ 2.44 | $ 2.33 | |
| Mar 19, 2026 | -$ 0.14 | $ 2.92 | $ 2.88 | |
| Nov 5, 2025 | -$ 0.10 | $ 1.11 | $ 1.07 | |
| Aug 6, 2025 | -$ 0.09 | $ 0.70 | $ 0.699 | |
| May 7, 2025 | -$ 0.05 | $ 0.8076 | $ 0.7732 | |
| Mar 20, 2025 | -$ 0.04 | $ 0.8192 | $ 0.7718 | |
| Nov 6, 2024 | -$ 0.22 | $ 2.21 | $ 2.09 | |
| Aug 7, 2024 | -$ 0.04 | $ 2.31 | $ 2.40 | |
| May 8, 2024 | -$ 0.23 | $ 1.72 | $ 1.83 | |
| Mar 21, 2024 | -$ 0.42 | $ 1.15 | $ 1.17 | |
| Nov 9, 2023 | -$ 0.37 | $ 1.06 | $ 1.06 | |
| Aug 9, 2023 | -$ 0.31 | $ 1.04 | $ 1.04 | |
| May 10, 2023 | -$ 0.40 | $ 0.6004 | $ 0.5805 | |
| Mar 22, 2023 | -$ 0.22 | $ 0.66 | $ 0.6099 | |
| Nov 9, 2022 | -$ 0.24 | $ 1.15 | $ 1.16 | |
| Aug 11, 2022 | -$ 0.25 | $ 1.85 | $ 1.96 | |
| May 11, 2022 | -$ 0.22 | $ 1.36 | $ 1.38 | |
| Mar 24, 2022 | -$ 0.30 | $ 2.27 | $ 2.25 |
Context Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Context Therapeutics beat analysts’ expectations during the last earnings period by
